CRL vs WHWK · rev $2.00B vs $202.8M cap
Charles River Laboratories (CRL) versus Whitehawk Therapeutics, Inc. (WHWK) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Whitehawk Therapeutics, Inc. (WHWK) is a biotechnology company listed on NASDAQ.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported WHWK revenue for 2026-06-30 was $0. Net income was -$38.8M. WHWK currently screens at market cap $202.8M.
CRL currently screens at market cap $7.78B. WHWK currently screens at market cap $202.8M.
Not investment advice. Open the CRL and WHWK stock pages for the full models.
Not investment advice.